Martine A. Rothblatt

CEO · UNITED THERAPEUTICS Corp

Rank #3,506 SEC EDGAR (United States) ↗

Details

Officer and board memberPharmaceuticals & BiotechnologyUTHRSEC CIK 0001106578

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$25.2M
1-day change
▼ 0.53%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 44 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-11-07$23.2M – $30.4M2026-09-04

Insider activity Apr 1, 2024 – Mar 30, 2026

Martine A. Rothblatt is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 1,291 transactions between Apr 1, 2024 and Mar 30, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$363.79M
1,087 sales on file priced rows only
All reported transactions
1,291
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,691,360 on Sep 30, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,691,360 on Sep 30, 2025
Date Insider Transaction Shares Price Value Filing
Sep 30, 2025 Martine A. Rothblatt S Open-market sale 4,000 held after: 130 $422.84 $1,691,360 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,644,320 on Sep 19, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,644,320 on Sep 19, 2025
Date Insider Transaction Shares Price Value Filing
Sep 19, 2025 Martine A. Rothblatt S Open-market sale 4,000 held after: 130 $411.08 $1,644,320 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,588,920 on Sep 11, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Martine A. Rothblatt sold 4,000 UNITED THERAPEUTICS Corp (UTHR) shares for $1,588,920 on Sep 11, 2025
Date Insider Transaction Shares Price Value Filing
Sep 11, 2025 Martine A. Rothblatt S Open-market sale 4,000 held after: 130 $397.23 $1,588,920 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Martine A. Rothblatt sold 6,165 UNITED THERAPEUTICS Corp (UTHR) shares for $2,455,458 on Sep 9, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Martine A. Rothblatt sold 6,165 UNITED THERAPEUTICS Corp (UTHR) shares for $2,455,458 on Sep 9, 2025
Date Insider Transaction Shares Price Value Filing
Sep 9, 2025 Martine A. Rothblatt S Open-market sale 6,165 held after: 1,965 $398.29 $2,455,458 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 3 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 2,639 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. UNITED THERAPEUTICS Corp UTHR S Open-market sale × 10 9,500 shares $4.77M
    The 10 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    280 $508.80 $142.5K SEC filing ↗
    280 $506.76 $141.9K SEC filing ↗
    600 $505.94 $303.6K SEC filing ↗
    702 $505.03 $354.5K SEC filing ↗
    578 $503.76 $291.2K SEC filing ↗
    1,536 $502.80 $772.3K SEC filing ↗
    2,244 $501.88 $1.13M SEC filing ↗
    1,372 $500.58 $686.8K SEC filing ↗
    1,788 $499.75 $893.6K SEC filing ↗
    120 $498.44 $59.8K SEC filing ↗
  2. UNITED THERAPEUTICS Corp UTHR M Option exercise or conversionnot a buy/sell decision 9,500 shares $1.12M at $117.76 SEC filing ↗
  3. UNITED THERAPEUTICS Corp UTHR S Open-market sale × 14 9,500 shares $4.77M
    The 14 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    200 $509.00 $101.8K SEC filing ↗
    506 $507.68 $256.9K SEC filing ↗
    794 $506.84 $402.4K SEC filing ↗
    875 $505.78 $442.6K SEC filing ↗
    964 $505.03 $486.8K SEC filing ↗
    1,144 $503.60 $576.1K SEC filing ↗
    1,017 $502.87 $511.4K SEC filing ↗
    361 $500.84 $180.8K SEC filing ↗
    519 $499.73 $259.4K SEC filing ↗
    400 $498.85 $199.5K SEC filing ↗
    160 $497.56 $79.6K SEC filing ↗
    1,278 $496.73 $634.8K SEC filing ↗
    1,202 $495.65 $595.8K SEC filing ↗
    80 $493.81 $39.5K SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
UNITED THERAPEUTICS Corp UTHR Common Stock 51,641 $487.61 $25.2M 4 EDGAR ↗
BETA Technologies, Inc. BETA Class A common stock 1,071 $22.20 $23.8K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Martine A. Rothblatt reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.